Halina Was,
Malgorzata Sokolowska,
Aleksandra Sierpniowska,
Paweł Dominik,
Klaudia Skrzypek,
Bozena Lackowska,
Antoni Pratnicki,
Anna Grochot-Przeczek,
Hevidar Taha,
Jerzy Kotlinowski,
Magdalena Kozakowska,
Andrzej Mazan, Witold Nowak,
Lucie Muchova,
Libor Vitek,
Anna Ratajska,
Jozef Dulak,
Alicja Jozkowicz
[show abstract]
[hide abstract]
ABSTRACT: Heme oxygenase-1 (HO-1) is an antioxidative and cytoprotective enzyme, which may protect neoplastic cells against anticancer therapies, thereby promoting the progression of growing tumors. Our aim was to investigate the role of HO-1 in cancer induction. Experiments were performed in HO-1(+/+), HO-1(+/-), and HO-1(-/-) mice subjected to chemical induction of squamous cell carcinoma with 7,12-dimethylbenz[a]anthracene and phorbol 12-myristate 13-acetate. Measurements of cytoprotective genes in the livers evidenced systemic oxidative stress in the mice of all the HO-1 genotypes. Carcinogen-induced lesions appeared earlier in HO-1(-/-) and HO-1(+/-) than in wild-type animals. They also contained much higher concentrations of vascular endothelial growth factor and keratinocyte chemoattractant, but lower levels of tumor necrosis factor-α and interleukin-12. Furthermore, tumors grew much larger in HO-1 knockouts than in the other groups, which was accompanied by an increased rate of animal mortality. However, pathomorphological analysis indicated that HO-1(-/-) lesions were mainly large but benign papillomas. In contrast, in mice expressing HO-1, most lesions displayed dysplastic features and developed to invasive carcinoma. Thus, HO-1 may protect healthy tissues against carcinogen-induced injury, but in already growing tumors it seems to favor their progression toward more malignant forms.
Free radical biology & medicine 08/2011; 51(9):1717-26. · 5.42 Impact Factor